The multikinase inhibitor EC‐70124 synergistically increased the antitumor activity of doxorubicin in sarcomas-Reference-Cited by-同舟云学术

The multikinase inhibitor EC‐70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

Published:2019-01-14 Issue:1 Volume:145 Page:254-266
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Estupiñan Oscar¹²³,Santos Laura¹,Rodriguez Aida¹,Fernandez‐Nevado Lucia¹,Costales Paula⁴,Perez‐Escuredo Jhudit⁴,Hermosilla Maria Ana⁴,Oro Patricia⁴,Rey Veronica¹²,Tornin Juan¹²,Allonca Eva¹,Fernandez‐Garcia Maria Teresa⁵,Alvarez‐Fernandez Carlos⁶,Braña Alejandro⁷,Astudillo Aurora⁸,Menendez Sofia T¹²³,Moris Francisco⁴,Rodriguez Rene¹²³^ORCID

Affiliation:

1. Hospital Universitario Central de Asturias ‐ Instituto de Investigación Sanitaria del Principado de Asturias Oviedo Spain

2. Instituto Universitario de Oncología del Principado de Asturias Oviedo Spain

3. CIBER en oncología (CIBERONC) Madrid Spain

4. EntreChem SL Oviedo Spain

5. Unidad Histopatología Molecular en Modelos Animales de Cáncer, IUOPA, Universidad de Oviedo Oviedo Spain

6. Servicio de Oncología Médica of the Hospital Universitario Central de Asturias Oviedo Spain

7. Servicio de Traumatología of the Hospital Universitario Central de Asturias Oviedo Spain

8. Servicio de Anatomía Patológica of the Hospital Universitario Central de Asturias Oviedo Spain

Funder

Center for Biomedical Research Network

Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32081

Reference50 articles.

1. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies

2. Modeling sarcomagenesis using multipotent mesenchymal stem cells

3. Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network

4. Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models

5. Chemotherapy for soft tissue sarcoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma;eBioMedicine;2024-04

2. Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells;Free Radical Biology and Medicine;2023-11

3. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma;2023-09-12

4. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling;Biomedicine & Pharmacotherapy;2023-06

5. Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer;Free Radical Biology and Medicine;2022-08